01/06/2023
3:16 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2022
3:42 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2022
7:05 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2022
4:43 PM | Atara Biotherapeutics (Issuer)
Banard Charlene A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/18/2022
7:13 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2022
7:13 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/18/2022
7:13 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2022
7:13 PM | Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2022
3:20 PM | Atara Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/28/2022
3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2022
3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2022
5:20 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2022
5:21 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2022
5:21 PM | Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2022
5:24 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2022
3:14 PM | Atara Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/22/2022
3:06 PM | Atara Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/29/2022
3:48 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2022
3:48 PM | Atara Biotherapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2022
3:48 PM | Atara Biotherapeutics (Issuer)
Renaud Ronald C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2022
3:48 PM | Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2022
3:48 PM | Atara Biotherapeutics (Issuer)
Baynes Roy D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2022
3:48 PM | Atara Biotherapeutics (Issuer)
Roncarolo Maria Grazia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2022
3:48 PM | Atara Biotherapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2022
3:48 PM | Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2022
3:48 PM | Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2022
3:48 PM | Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2022
3:02 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2022
4:16 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2022
4:20 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2022
4:04 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2022
4:08 PM | Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2022
3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2021
6:32 PM | Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2021
6:34 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2021
6:35 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2021
6:36 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2021
6:37 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2021
3:02 PM | Atara Biotherapeutics (Issuer)
Yarema Kristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2021
6:09 PM | Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/09/2021
6:11 PM | Atara Biotherapeutics (Issuer)
Roncarolo Maria Grazia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2021
6:13 PM | Atara Biotherapeutics (Issuer)
Renaud Ronald C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2021
6:14 PM | Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2021
6:16 PM | Atara Biotherapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2021
6:03 PM | Atara Biotherapeutics (Issuer)
Baynes Roy D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2021
6:05 PM | Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2021
6:07 PM | Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2021
3:06 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2021
3:29 PM | Atara Biotherapeutics (Issuer)
Yarema Kristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2021
3:30 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2021
3:31 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2021
3:32 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2021
3:32 PM | Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2021
3:33 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2021
5:32 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2021
3:36 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/30/2021
4:18 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/30/2021
4:19 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2021
6:25 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2021
4:13 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2021
4:14 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2021
4:15 PM | Atara Biotherapeutics (Issuer)
Yarema Kristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2021
4:15 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2021
4:16 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2021
4:17 PM | Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2021
4:05 PM | Atara Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/09/2021
6:59 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2021
6:59 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2021
3:02 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2021
6:31 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2020
5:35 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2020
4:08 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2020
7:26 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2020
3:07 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2020
3:07 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2020
3:08 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2020
3:19 PM | Atara Biotherapeutics (Issuer)
Atara Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2020
3:41 PM | Atara Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/09/2020
3:11 PM | Atara Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2020
3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2020
6:37 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2020
6:38 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2020
6:39 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2020
3:18 PM | Atara Biotherapeutics (Issuer)
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
8:15 PM | Atara Biotherapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
4:43 PM | Atara Biotherapeutics (Issuer)
Baynes Roy D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
4:44 PM | Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
4:45 PM | Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
4:46 PM | Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
4:46 PM | Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/20/2020
5:10 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
5:11 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
5:11 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
6:16 PM | Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/19/2020
6:17 PM | Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2020
6:43 PM | Atara Biotherapeutics (Issuer)
Renaud Ronald C JR (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2020
6:44 PM | Atara Biotherapeutics (Issuer)
Renaud Ronald C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2020
4:25 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2020
3:16 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/21/2020
3:17 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
